SCHEMBL4843406

SCHEMBL4843406

COCCN1C(=O)C(N2C(=O)c3ccccc3C2=O)CC=C[C@H]1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
CYP2C9 P11712 1/20 0.36
GAA P10253 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
FPR1 P21462 1/20 0.35
LMNA P02545 1/20 0.35
ALOX15 P16050 1/20 0.34
MAPT P10636 2/20 0.34
RECQL P46063 1/20 0.34
MAPK1 P28482 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14254617 1.00 ALDH1A1 (0.37) ALDH1A1FNTAFNTBSMN1; SMN2CYP2C9
SCHEMBL4833337 0.83 NPSR1 (0.34) ALDH1A1SMN1; SMN2TSHRMAPTMEN1
SCHEMBL8314206 0.83 NPSR1 (0.34) ALDH1A1SMN1; SMN2TSHRMAPTMEN1
SCHEMBL8313398 0.81 ALDH1A1 (0.42) ALDH1A1MAPTCTDSP1MEN1KMT2A
SCHEMBL4838497 0.81 ALDH1A1 (0.42) ALDH1A1MAPTCTDSP1MEN1KMT2A
SCHEMBL8313412 0.81 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMAPTMEN1
SCHEMBL4845001 0.81 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMAPTMEN1
SCHEMBL5795559 0.80 ALDH1A1 (0.38) ALDH1A1FNTAFNTBSMN1; SMN2CYP2C9
SCHEMBL4841551 0.80 ALDH1A1 (0.38) ALDH1A1FNTAFNTBSMN1; SMN2CYP2C9
SCHEMBL4841082 0.80 ALDH1A1 (0.38) ALDH1A1FNTAFNTBSMN1; SMN2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-20060183732-A1 Novel lactams and uses thereof ASTRAZENECA AB (SE) 2006-08-17 US disclosed
EP-1636196-A1 NOVEL LACTAMS AND USES THEREOF AstraZeneca AB (SE) 2006-03-22 EP disclosed
WO-2004080983-A1 NOVEL LACTAMS AND USES THEREOF ASTRAZENECA AB (SE) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183732-A1 Novel lactams and uses thereof BACE1, BACE2, APP ALDH1A1 2419/4885FNTA 178/4885FNTB 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.